Tirzepatide 40mg Injection Pen Kit (R&D Only)

As the manufacturer, Synedica produces this Tirzepatide 40mg Injection Pen Kit for laboratory research, supplied in a convenient pre-filled format. Buying direct from our official store means you’re getting the genuine product, with full batch traceability back to our own production.

About This Pen Kit

Tirzepatide is a synthetic peptide of significant interest in current metabolic research, studied as a dual agonist acting on GIP and GLP-1 receptor pathways. This kit format offers a pre-measured research solution, designed for ease of handling in laboratory settings.

Each kit we produce is:

• Formulated to high-purity standards
• Supplied as a pre-filled pen for controlled laboratory use
• Sealed and batch-tested before dispatch
• Supplied strictly for research and development (R&D) purposes

Why Buy Direct From Synedica

• Genuine product straight from the manufacturer
• Full batch traceability on every order
• Consistent purity standards across every production run
• Fast UK dispatch

Storage & Handling

• Store the pen in a refrigerator (2–8°C), away from direct light and heat
• Avoid shaking or exposing the pen to extreme temperatures
• Use appropriate sterile technique when handling for laboratory use
• Follow standard peptide-handling protocols for storage after first use

Important Notice — Research Use Only

This product is sold strictly for laboratory research and development purposes. It is not for human or animal consumption, not a medicine, supplement, or cosmetic product, and has not been evaluated by the MHRA or FDA for any therapeutic use. Intended only for qualified individuals in appropriate research settings.

---

Frequently Asked Questions

Is this a genuine Synedica product? Yes — this is sold directly through our official store, manufactured by us.

Is the Tirzepatide 40mg Injection Pen Kit suitable for human use? No. This product is for research and development purposes only.

Where can I see your other products? Browse our full Synedica range, or visit our homepage to learn more about us.